New York City, NY, 20 January, 2020/ 24 Market Reports: The global flow cytometry market is estimated to grow from USD 4.4 billion in 2019 and reach that of USD 6.1 billion by 2025 witnessing the growth at a CAGR of 8.2% during the forecast period of 2019 to 2025. Technological advancements in flow cytometers, the increasing adoption of flow cytometry techniques in research activities and clinical trials, growing focus on immunology and immuno-oncology research, increasing incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software, high incidence and prevalence of HIV-AIDS and cancer, and the increasing availability of novel application-specific flow cytometry products are the factors that are driving the growth of the market during the forecast period.
The growing market penetration in emerging countries, growth in stem cell research and adoption of recombinant DNA technology for antibody production and evolution of tandem flow cytometry technologies are also the factors that are estimated to drive the growth of the market during the forecast period.
Cell-based and bead-based flow cytometry is the segmentation for the global flow cytometry market based on technology. During the forecast period, it is estimated for the bead-based flow cytometry segment to witness the growth at the highest CAGR. Including the capacity of the bead-based flow cytometry segment to detect multiple analytes, high reproducibility, stability and speed the procedural advantages offered by this technology over other cell-based technology is driving the growth of the segment during the forecast period.
Reagents and consumables, instruments, services, software and accessories are the segmentation for the market during the forecast period based on product and service. The reagents and consumables category is estimated to lead the segment during the forecast period. The development and commercialization of high-quality application-specific reagents and assays and the continuous requirement of flow cytometry reagents by end-users are the factors that are estimated to drive the growth of the segment during the forecast period.
North America, Europe, the Asia Pacific, Latin America and the Middle East and Africa are the segmentation for the global flow cytometry market based on geography. Followed by Europe, during the forecast period it is estimated for North America to dominate the market. However, the Asia Pacific region is estimated to witness the fastest growth in the market. The participation of the countries of the region such as China, India, Japan, Australia, and South Korea in flow cytometry-based research; expansion of research infrastructure; and increasing public-private initiative aimed towards boosting advance research practices in the region is boosting the growth of the market.